Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17)

Stephen Boorjian

doi:10.1016/j.urolonc.2011.07.020

Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17)

Stephen Boorjian

Urology

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	584-585
Number of pages	2
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	29
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2011.07.020
State	Published - Sep 2011

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2011.07.020

Cite this

Boorjian, S. (2011). Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17). Urologic Oncology: Seminars and Original Investigations, 29(5), 584-585. https://doi.org/10.1016/j.urolonc.2011.07.020

Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17). / Boorjian, Stephen.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 29, No. 5, 09.2011, p. 584-585.

Research output: Contribution to journal › Short survey › peer-review

Boorjian, S 2011, 'Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17)', Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 5, pp. 584-585. https://doi.org/10.1016/j.urolonc.2011.07.020

Boorjian S. Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17). Urologic Oncology: Seminars and Original Investigations. 2011 Sep;29(5):584-585. doi: 10.1016/j.urolonc.2011.07.020

Boorjian, Stephen. / Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features : Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17). In: Urologic Oncology: Seminars and Original Investigations. 2011 ; Vol. 29, No. 5. pp. 584-585.

@article{df31b96853794fa5869bc9f3694412ec,

title = "Commentary on {"}Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment.{"} Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17)",

author = "Stephen Boorjian",

year = "2011",

month = sep,

doi = "10.1016/j.urolonc.2011.07.020",

language = "English (US)",

volume = "29",

pages = "584--585",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Commentary on "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features

T2 - Comparison with nephrectomy assessment." Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX. J Urol 2010;184:1877-81 (Epub 2010 Sep 17)

AU - Boorjian, Stephen

PY - 2011/9

Y1 - 2011/9

UR - http://www.scopus.com/inward/record.url?scp=80052959951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052959951&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2011.07.020

DO - 10.1016/j.urolonc.2011.07.020

M3 - Short survey

AN - SCOPUS:80052959951

SN - 1078-1439

VL - 29

SP - 584

EP - 585

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this